Search
Exicure Inc
XCURAdd to Watchlist
1.910USD
-0.110-5.56%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
12.17MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-5.56%
5 Days
-20.42%
1 Month
-35.47%
6 Months
-65.77%
Year to Date
-64.76%
1 Year
-71.83%
Key Figures
1.960Open
1.965High
31.70KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.50%Turnover Ratio
1.980Prev. Close
1.880Low
50.80KTurnover
LossP/E Static
5.80P/B
0.00%Div Yield TTM
-34.00%ROA
10.80052wk High
0.91Volume Ratio
-9.70MNet Profit
6.37MShares
-0.7854EPS TTM
3.53Beta
-92.47%ROE
2.62752wk Low
4.29%Amplitude
100.00%Gross Margin
12.17MMarket Cap
-5.49Reward/Risk
6.03%Risk Rate
TradingKey Stock Score of Exicure Inc
Currency: USD Updated: 2026-07-02Key Insights
Exicure Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 233 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Exicure Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Exicure Inc Highlights
StrengthsRisks
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.
Undervalued
The company’s latest PE is -2.43, at a low 3-year percentile range.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Exicure Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Exicure Inc Info
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.
Ticker SymbolXCUR
CompanyExicure Inc
CEOYoo (Andy)
Websitehttps://www.exicuretx.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Exicure Inc (XCUR)?
The current price of Exicure Inc (XCUR) is 1.91.
What is the symbol of Exicure Inc?
The ticker symbol of Exicure Inc is XCUR.
What is the 52-week high of Exicure Inc?
The 52-week high of Exicure Inc is 10.80.
What is the 52-week low of Exicure Inc?
The 52-week low of Exicure Inc is 2.63.
What is the market capitalization of Exicure Inc?
The market capitalization of Exicure Inc is 12.17M.
What is the Earnings Per Share (EPS TTM) of Exicure Inc (XCUR)?
The Earnings Per Share (EPS TTM) of Exicure Inc (XCUR) is -0.79.